Initiation of Oseltamivir in Critically Ill Patients: Variations in Prescribing Practices.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Works matching IS 10600280 AND DT 2021 AND VI 55 AND IP 2
Results: 17
1
2
Optimization of Sedative Therapies Leads to Potential Pentobarbital Cost Avoidance in Treatment of Refractory Intracranial Hypertension.
- Published in:
- 2021
- By:
- Publication type:
- Letter
3
Effectiveness of Quetiapine as a Sedative Adjunct in Mechanically Ventilated Adults Without Delirium.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 149, doi. 10.1177/1060028020944409
- By:
- Publication type:
- Article
4
Safety and Efficacy of a Percutaneously Inserted Ventricular Support Device Purge Solution Heparin 25 U/mL.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 174, doi. 10.1177/1060028020944831
- By:
- Publication type:
- Article
5
Tolerability of Highly Protein Bound Targeted Oral Oncolytic Drugs in Patients With Hypoalbuminemia: A Retrospective Analysis.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 165, doi. 10.1177/1060028020942485
- By:
- Publication type:
- Article
6
Ibalizumab: The First Monoclonal Antibody for the Treatment of HIV-1 Infection.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 230, doi. 10.1177/1060028020942218
- By:
- Publication type:
- Article
7
Safety of Intravenous Push Lacosamide Compared With Intravenous Piggyback at a Tertiary Academic Medical Center.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 181, doi. 10.1177/1060028020943569
- By:
- Publication type:
- Article
8
Colchicine in Acute Coronary Syndrome: A Systematic Review.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 187, doi. 10.1177/1060028020942144
- By:
- Publication type:
- Article
9
Hydrogen Peroxide 40% for the Treatment of Seborrheic Keratoses.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 216, doi. 10.1177/1060028020941793
- By:
- Publication type:
- Article
10
Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 198, doi. 10.1177/1060028020943542
- By:
- Publication type:
- Article
11
Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 261, doi. 10.1177/1060028020943160
- By:
- Publication type:
- Article
12
Voxelotor: A Novel Treatment for Sickle Cell Disease.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 240, doi. 10.1177/1060028020943059
- By:
- Publication type:
- Article
13
Bempedoic Acid: A New Drug for an Old Problem.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 246, doi. 10.1177/1060028020941083
- By:
- Publication type:
- Article
14
Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 222, doi. 10.1177/1060028020941014
- By:
- Publication type:
- Article
15
Association Between the Prothrombin Time–International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of Bacteroides fragilis to Antibiotics.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 157, doi. 10.1177/1060028020940728
- By:
- Publication type:
- Article
16
Safety of Continuous Neostigmine for the Treatment of Impaired Gastrointestinal Motility in Pediatric Patients.
- Published in:
- 2021
- By:
- Publication type:
- Letter
17
Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 252, doi. 10.1177/1060028020934001
- By:
- Publication type:
- Article